BON-WAC

Complete SYSADOA (Symptomatic Slow-Acting Drug for Osteoarthritis) and Dual COX-2/5-LOX Inflammatory Modulator.

Active Clinical Composition: Complete SYSADOA, 5 LOX and COX 2 Inhibitors
(2 customer reviews)

₨ 1,180

BON WAC os a complete SYSADOA (Symptomatic Slow-Acting Drug for Osteoarthritis) and Dual COX-2/5-LOX Inflammatory Modulator.

Mechanism of Action: BON-WAC operates through a Dual-Pathway architecture to restore joint integrity and bypass the pro-inflammatory “NSAID Shunt”:

  • Pathway A (Structural Matrix / Complete SYSADOA): Halts MMP-driven catabolism and provides direct organic substrates to restore chondrocyte metabolism and synthesize Type II collagen.

    • Glucosamine Sulphate: Drives glycosaminoglycan (GAG) and hyaluronic acid biosynthesis.

    • Chondroitin Sulphate: Restores hydraulic fluid retention and competitively suppresses collagenase enzymes.

    • MSM: Acts as an essential organic sulfur donor required for stable disulfide bond formation.

  • Pathway B (Inflammatory Modulator): Actively suppresses synovial inflammation without precipitating gastro-hepatic or renal toxicity.

    • Boswellia Serrata API (AKBA Standardized): Acts as a direct 5-LOX pathway inhibitor, halting pro-inflammatory leukotriene (LTB4) synthesis to rapidly resolve swelling.

    • Curcumin USP: Intercepts COX-2 cascades to downregulate TNF-α and IL-1β, safely resolving nociceptive pain.

Pharmacokinetics (The Lipid Rule): To guarantee maximum bioavailability, the active botanical extracts (Curcumin and Boswellia) require dietary lipids to maximize lymphatic bypass absorption.

BON-WAC is clinically indicated for the management of joint pathology and structural degradation:

  • Osteoarthritis (OA) – Stages I–III / Load-Bearing: Acts as a foundational Step-1 Complete SYSADOA to halt joint space narrowing and aggressively restore chondrocyte vitality.

  • Lumbar Spondylosis (Facet-Joint Architecture): Preserves spinal cartilage integrity while providing targeted 5-LOX modulation to resolve localized spinal inflammation and chronic back pain.

  • Rheumatoid Arthritis (The NSAID-Sparing Adjunct): Serves as a potent NSAID-sparing shield by down-regulating leukotriene-induced synovial swelling without compounding toxic daily analgesic burdens.

  • Clinical Efficacy vs. Standard Care: Unlike chronic NSAIDs which trigger the 5-LOX “NSAID Shunt” (exacerbating swelling) and risk gastric erosion or AKI, BON-WAC guarantees 100% gastro-mucosal and renal safety. Furthermore, it provides complete matrix rebuilding substrates with zero diarrheal or hepatotoxic liabilities, unlike Diacerein.

Active SubstanceStrength per Unit
Glucosamine Sulphate500mg
Chondroitin Sulphate 100mg-
Methylsulfonylmethane200mg
Boswellia Serrata API50mg
Curcumin USP50mg

* Excipients and coating agents not listed. Refer to full SMPC for complete profile.

  • Acute / Loading Dose (Weeks 1-4): 1 Tablet Three Times Daily (TDS). This rapidly saturates the joint matrix with structural substrates and establishes an optimal baseline of 5-LOX modulation to halt acute inflammatory flare-ups.

  • Maintenance Dose (Months 2-6): 1 Tablet Twice Daily (BID). A minimum 3-month continuous cycle is pharmacologically required for complete structural Type II collagen cross-linking and long-term joint preservation.

  • Administration Requirement: Must be administered strictly with or immediately after lipid-containing meals to maximize absorption.

  • Absolute Contraindications: Strictly contraindicated in patients with active biliary obstruction (symptomatic gallstones) due to the cholagogue properties of Curcumin.

  • Drug Interactions: May exert synergistic pharmacodynamic effects with Vitamin K Antagonists (e.g., Warfarin); clinicians should monitor INR closely during concurrent therapy.

Scientific Literature & Global Guidelines
  1. Bruyère, O., et al. (2019). An algorithmic recommendation for knee osteoarthritis management: A core consensus statement from the ESCEO. Semin Arthritis Rheum.
  2. Safayhi, H., et al. (1992). Boswellic acids: structurally novel, highly specific, nonredox direct inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther.

2 reviews for BON-WAC

  1. Avatar Of Shadman Khalil

    Shadman Khalil –

    Bon-Wac has been a game-changer for my joint health. After consistent use, I’ve noticed a significant reduction in discomfort and an improvement in mobility. It’s reassuring to know that the product meets high-quality standards with GMP, DRAP, and Halal certifications.

  2. Avatar Of Sobaina Mujeeb

    Sobaina Mujeeb –

    I got this for my mom, and the results have been Amazing. Before trying em on wax D, we tried a lot of different medications but nothing quite worked like Bon wac d. Ever since my mom started taking it, it’s like she has forgotten all abt her knee Osteoarthritis

Add a review

Your email address will not be published. Required fields are marked *